Home - Prescription Medicines - Casodex® | Bicalutamide Tablets | Metastatic Prostate Cancer | DengYueRX
Description
Indication & Scope
Bicalutamide Tablets (Casodex®) is a selective nonsteroidal androgen receptor antagonist. It competitively binds to androgen receptors in prostate tumor cells, blocks intracellular androgen signal transduction, suppresses proliferation of androgen-dependent prostate cancer cells and induces tumor cell apoptosis.
- Mechanism
Selective nonsteroidal anti-androgen agent - Drug class
Prescription oral endocrine antitumor medicine for prostate cancer - Clinical use
Locally advanced and metastatic prostate cancer in male patients
| Generic Name | Bicalutamide Tablets |
| Brand Name | Casodex® |
| Ingredient | Bicalutamide |
| Dosage Form | Film-coated Tablets |
| Package | 50mg*28 tablets/box |
| Conditions Treated | Combined use with LHRH analogues or surgical castration for advanced metastatic prostate cancer in male patients; Single-agent therapy for locally advanced non-metastatic prostate cancer unsuitable for immediate surgery or radiotherapy |
| Taboos | Women and children |
| Place of origin | Plankstadt, Germany |
| Priscription Type | Prescription Drug |
| Storage Conditions | Sealed, store below 30°C, protected from light |
| Manufacturer | CORDEN PHARMA GMBH |
| Registration Authority | National Medical Products Administration (NMPA) |
| Approval number | HJ20140720 |
| Approval Date | November 30, 2023 |
| Shelf Life | 60 months |
How to use ?
Recommended Dose: Standard dosage regimen: 50 mg orally once daily for metastatic prostate cancer, combined with LHRH analogues simultaneously.
Time: Fixed daily oral administration; continuous medication until disease progression or intolerable toxicity. Food intake has no influence on absorption.
Interaction: Bicalutamide inhibits CYP3A4; blood concentration monitoring is required when combined with drugs metabolized via CYP3A4 such as warfarin, statins and calcium channel blockers.
Side effects: Common reactions: Hot flushes, gynecomastia, breast tenderness, fatigue, constipation, nausea, decreased libido, erectile dysfunction. Long-term risks: Osteoporosis, anemia, elevated blood lipid levels. Rare severe adverse events: Transaminase elevation, rash, systemic hypersensitivity.
Important Notice
This product shall only be used for post-exposure rabies prophylaxis by professional medical staff. It must be applied combined with rabies vaccine and injected via wound infiltration plus intramuscular routes as specified. Do not administer intravenously or alter the dosage at will. Hypersensitivity monitoring is required throughout the whole injection process.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
What is the core pharmacological function of bicalutamide?
It blocks androgen receptors to inhibit the proliferation of androgen-driven prostate cancer cells.
Does bicalutamide shrink prostate cancer?
This may shrink the prostate cancer or stop it growing.
What to avoid when taking bicalutamide?
Bicalutamide may cause serious bleeding when you use it together with a blood thinner medicine (eg, warfarin).
What happens if I stop taking bicalutamide?
It takes approximately 30 days for most of the Casodex to be removed from your body.
Casodex® | Bicalutamide Tablets | Metastatic Prostate Cancer | DengYueRX
INN: Bicalutamide
Indications: Metastatic Prostate Cancer
Dosage Form: Film-coated Tablets
Strength: 50mg/Tablet
$219.03 Original price was: $219.03.$186.18Current price is: $186.18.